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Objective:   To study the expression regularity of vas-
cular endothelial growth factor (VEGF) during the process
of fracture healing, and the type of VEGF receptor expressed
in the vascular endothelial cells of the fracture site.
  Methods:   The fracture model was made in the middle
part of  left radius in 35 rabbits. The specimens from the
fracture site were harvested at 8, 24, 72 hours and 1, 3, 5, 8
weeks, and then fixed, decalcified, and sectioned frozenly
to detect the expression of VEGF and its receptor at the
fracture site by in situ hybridization and immunochemical
assays.
Results:  VEGF mRNA and VEGF expression was de-
tected in many kinds of cells at the fracture site during 8
hours to 8 weeks after fracture. Flt1 receptor of VEGF was
found in the vascular endothelial cells at the fracture site
during 8 hours to 8 weeks after fracture, and strong expres-
sion of flk1 receptor was detected from 3 days to 3 weeks
after fracture.
Conclusions:  The expression of VEGF and flt1 receptor
appears during the whole course of fracture healing, espe-
cially from 1 to 3 weeks. Flk1 receptor is highly expressed in
a definite period after fracture. VEGF is proved to be in-
volved in the vascular reconstruction and fracture healing.
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Vascular endothelial growth factor (VEGF) is onekind of glucoprotein isolated from bovine pitu-itary stellate cells by Ferrara et al.1  It has been
confirmed that many growth factors can accelerate
angiogenesis. Among them, VEGF is the most power-
ful one.  By combining with specific receptors on the
vascular endothelium, it can greatly promote endothe-
lial proliferation and angiogenesis. The angiogenesis
effect of other angiogenesis-promoting factors is car-
ried out completely or partly by enhancing the expres-
sion and production of VEGF.2  Since vascular recon-
struction appears during the whole course of fracture
healing, we managed to elucidate the mechanism of
fracture healing through studying the expression regu-
larity of VEGF and its receptors
METHODS
Grouping and animal model
A total of 35 healthy New Zealand white rabbits of
either sex, weighing 2.5-3 kg, were randomly divided
into 7 groups with 5 rabbits in each. Anesthesia was
conducted by intravenous injection of pentobarbital so-
dium via the posterior auricular vein. After routine
depilation, a 1.5 cm longitudinal incision was made lat-
erally at the middle part of the left forelimb under sterile
condition to expose the radius. After peeling off the
periosteum circularly about 1 mm apart from both sides,
the radius was cut down transversely with a 0.5 mm
diameter of dental drill. The wound was scavenged and
closed. Internal or external fixation was not necessary
because in rabbits the upper and lower ulnoradial joints
are congenital synostosis and hence the ulna can take
the action of fixation.3  Penicillin was injected intramus-
cularly after operation with 400 000 U, once daily for 3
days.
Sampling and assay
Animals were sacrificed respectively at 8, 24, 72
hours or 1, 3, 5, 8 weeks postoperatively with 5 rabbits
at each time point. The specimens were taken off from the
fracture site and fixed in a 4% paraform aldehyde solution
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(40 g/L) for 12 hours. Subsequently they were decalci-
fied in a 20% EDTA solution and under microwave
radiation.4 Five days later, the bony tissue was com-
pletely decalcified and frozen section was made (5 µm)
for in situ hybridization and immunohistochemistry
assay. At the same time, nonfractured radius was
harvested, processed, and assayed by the same way
as fractured one served as control.
Assay of VEGF mRNA expression
VEGF mRNA expression was detected by using
VEGF in situ hybridization kit (Boshide Co. Wuhan,
China) and the probes were (1)-CGAGA  TGGAG
GTGGT ACGGT  TCACC  AGGGT   CCGAC-, (2)-
CGTCG  AACTC  AATTT  GCTTG  CATGA  ACGTC
TACAC-, (3)-TTTGA  CGAGA  TCTCT  GTTTC  TGCAC
TACAA  TTATA-. The section was treated with 3% (v/v)
hydrogen peroxide and digested by pepsin to expose
mRNA. Oligonucleotide probes were added and hybrid-
ized at 370C overnight, and then blocking solution and
alkaline phosphatase-labelled DigiTAb were added. Af-
ter NBT/BCIP staining, gradient alcoholic dehydration,
xylene clearing, and DPX mounting, the specimens were
observed under microscope.
Assay of VEGF and its receptor expression
VEGF and its receptor expression was assayed by
using SP kit (Simplified Histostain Kit Zymed, Labora-
tories Inc, USA) and SP staining method. VEGF anti-
body and VEGF receptor antibody (Flk-1 and Flt-1 re-
ceptor antibody) were made in Santa Cruz, USA (diluting
200 folds). After frozen section with the thickness of 5
µm, the samples were treated with first and second
antibody, horseradish peroxidase labeling, initial stain-
ing with strepto-antibiotin and secondary staining with
hematoxylin, xylene clearing, DPX mounting, and ob-
served under microscope.
 RESULTS
Expression of VEGF mRNA and VEGF at the frac-
ture sites
The expression of VEGF mRNA and VEGF was
revealed at the fracture site and lasted from the begin-
ning to the end of the fracture healing and peaked at 1-
3 weeks. At 8 hours after fracture, a positive signal of
VEGF mRNA and VEGF was found and the expres-
sion was weak and scattered and mainly in the osteo-
cytes (Fig.1). At 1 week, a great deal of positive ex-
pression of VEGF mRNA and VEGF was noted in in-
flammatory cells, fibroblasts, and vascular endothelial
cells (Fig.2). VEGF mRNA and VEGF expression in
osteocytes was increased as well. At 3 weeks, a sig-
nificantly enhancing expression appeared in many kinds
of cells at the fracture sites. The bone cells, osteoblasts,
fibroblasts, and vascular endothelial cells were all in-
volved in the expression of VEGF mRNA and VEGF
(Fig.3). At 5 weeks, the expression became weak and
was mainly detected in bone cells and osteoblasts. At
8 weeks the expression was found only in osteoclasts
and normal bone tissues failed to find VEGF mRNA
and VEGF expression.
Expression of VEGF receptor in the endothelium
of fracture sites
At 8 hours after fracture, VEGF flt1 receptor ex-
pression was revealed in the vascular-endothelial sys-
tem of bone tissues at the fracture sites, enhanced
gradually and peaked at 1-3 weeks (Fig.4), and after
that it declined. At 3 weeks, a great deal of VEGF flt1
receptor expression was exhibited in the newly grown
capillary endothelium of the fracture sites. At 5 weeks
a positive flt1 signal was found in the chondrocytes of
fracture sites. During the whole course of the fracture
healing, the strong positive expression of flt1 receptor
in the chondrocytes appeared from 3 days to 3 weeks
after insult and meanwhile a positive signal of flt1 re-
ceptor was detected in the chondrocytes.
DISCUSSION
We found in this experiment VEGF mRNA and
VEGF expression during a whole course of fracture
healing. Different stages of fracture healing showed dif-
ferent kinds of cells involved in VEGF expression. The
expression peaked at 1-3 weeks after fracture with bone
cells and inflammatory cells dominated at early period
and vascular endothelial cells, osteoblasts, and fibro-
blasts at late stage. VEGF flt1 receptor expression
began at 8 hours, intensified gradually thereafter and
the strong positive expression lasted from 3 days to 3
weeks after fracture, which was coincident with the peak
time of VEGF expression. The finding that the imple-
ment of biological effect of VEGF relies on the specific
combination between VEGF and its receptors suggests
that VEGF participates in the reparative process of frac-
ture healing through inducing new vessel generation and
probably regulating fracture healing.
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It is now believed that VEGF is mainly expressed in
actively proliferated and function-vigorous tissue cells.
Many kinds of biological factors and hypoxia are gen-
erally responsible to VEGF expression.5 We postulate
that VEGF expression in several kinds of cells is re-
lated to cell hypoxia or active function appeared at that
time and in this way participates in fracture repair.  Local
blood circulation disturbance and osteocyte hypoxia
will take place after fracture, which may induce VEGF
expression. Those inflammatory cells aggregated fol-
lowing fracture and function-active osteoblasts,
fibroblasts, and vascular endothelial cells appeared at
the fracture sites during bone repair process all exhibit
strong expression activity of VEGF. The expression
activity declined along with the accomplishment of frac-
ture healing. At the 8th week when fracture turns into a
molding period, the osteoclasts that function as frac-
ture-molding cells express VEGF, but the mechanism
has not yet been clarified.
Two high-specific receptors combining with VEGF,
flt1 (fms-like tyrosine kinase) and flk1 (fetal liver kinase),
are found from the membranes of vascular endothelial
cells. They belong to the third subtype of tyrosine ki-
nase receptor family.6 In addition, vascular endothelial
cells specifically express flt4, also a tyrosine kinase
receptor. Different from flt1 and flk1, flt4 locates in the
stem cells of endothelial cells during the primary pe-
riod of embryogenesis. Thereafter it locates in venula
and lympho-endothelial cells. In adults it can only be
detected in lympho-endothelial cells. Generally VEGF
does not combine with flt4. In this experiment, the ex-
pression of both flt1 and flk1 receptors were detected
in the vascular endothelial cells at the fracture sites,
but the time of expression is greatly varied. The ex-
pression of flt1 receptor peaked during 1-3 weeks of
f racture healing, being coincident with VEGF
expression. A strong positive signal of Flk1 receptor
was noted at the fracture sites from 3 days to 3 weeks,
suggesting that both receptors participate in the repara-
tive process of fracture healing. It is worth noting that
the chondrocytes at fracture sites expressed flk1 and
flt1 receptors respectively at the 3rd and 5th weeks
after fracture. It was considered in the past that the two
receptors only expressed in vascular endothelial cells.
The expression in chondrocytes demonstrates that they
possess the characteristics of expression in non-vas-
cular endothelial cells and other functions. Although both
receptors have displayed certain degrees of inducing
character to VEGF, the regularity of flk1 receptor ex-
pression is not identical with VEGF expression, sug-
gesting other factors may take an important part in the
regulation of VEGF receptor expression, of which a suc-
cessive damage to blood vessels probably acts as a
regulating signal. The major effects of flk1 receptor are
related to accelerating the maturation of endothelial cells
and maintaining the number of hemopoietic progenitor
cells.7,8 The weakly-positive expression of flk1 receptor
during 3 weeks after fracture found in this study sug-
gests that the vascular reconstruction at fracture sites
has been fundamentally completed.
The peak expression of VEGF appears at 1-3 weeks
after fracture. From pathological viewpoint, this period
is the stage of vascular reconstruction. The vascular-
ization-inducing activity of VEGF is critical to vascular
reconstruction and fracture healing. It is generally be-
lieved that BMP and TGF-β participates in the pro-
cess of fracture healing and plays an important role in
regulating fracture healing.9,10 Our study demonstrates
that VEGF also participates in the process of fracture
healing.
Fig. 1. VEGF in oseocytes 8 hours after fracture (DAB×400). Fig. 2. VEGF in histomonocytes and fibroblasts 1 week after fracture
(DAB×400). Fig. 3. VEGF mRNA in fibroblasts, osteocytes and vascular endothelial cells 3 weeks after fracture (NBT/BCIP×400). Fig. 4.
Flt1 receptor in new vascular endothelial cells 3 weeks after fracture (DAB×400).
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